NEWS: 公告在东京证券交易所JASDAQ标准市场新上市

表纸
市场调查报告书

烫伤:全球临床试验检讨(2020年下半年)

Burns Disease - Global Clinical Trials Review, H2, 2020

出版商 GlobalData 商品编码 980196
出版日期 内容资讯 英文 291 Pages
订单完成后即时交付
价格
烫伤:全球临床试验检讨(2020年下半年) Burns Disease - Global Clinical Trials Review, H2, 2020
出版日期: 2020年12月30日内容资讯: 英文 291 Pages
简介

本报告提供烫伤的相关调查,提供世界主要国家中进行的实验数及其平均登记数概要,刊载各地区·阶段·临床试验现状·端点现状·赞助商类型的临床试验,进行临床试验中的药物,过去5年的登记趋势等资料。

目录

目录

表格清单

图清单

  • 报告指南
  • 临床试验调查范围
  • 各地区的临床试验
  • 各国临床试验与平均登记
  • 亚太地区中对临床试验有贡献的主要5个国家
  • 欧洲中对临床试验有贡献的主要5个国家
  • 北美中对临床试验有贡献的主要国家
  • 中东和非洲中对临床试验有贡献的主要5个国家
  • 中南美中对临床试验有贡献的主要5个国家
  • G7各国:皮肤科临床试验上烫伤的比例
  • 不同阶段:G7各国的临床试验
  • 各临床试验状态:G7各国的临床试验
  • E7各国:皮肤科临床试验上烫伤的比例
  • 不同阶段:E7各国的临床试验
  • 各临床试验状态:E7各国的临床试验
  • 不同阶段的临床试验
  • 不同阶段的进行中的临床试验
  • 各临床试验状态的临床试验
  • 各端点状态的临床试验
  • 特定连续期间内所募集的实验对象
  • 各赞助商类型的临床试验
  • 主要赞助商
  • 参加治疗药物临床实验的主要企业
  • 主要药物
  • 临床试验简介的概述

附录

  • 简称
  • 定义
  • 调查手法
  • 2次调查
  • 关于GlobalData
  • 咨询方式
  • 资讯来源

本网页内容可能与最新版本有所差异。详细情况请与我们联系。

目录
Product Code: GDHC6581CTIDB

GlobalData's clinical trial report, "Burns Disease - Global Clinical Trials Review, H2, 2020" provides an overview of Burns Clinical trials scenario. This report provides top line data relating to the clinical trials on Burns. Report includes an overview of trial numbers and their average enrollment in top countries conducted across the globe. The report offers coverage of disease clinical trials by region, country (G7 & E7), phase, trial status, end points status and sponsor type. Report also provides prominent drugs for in-progress trials (based on number of ongoing trials). GlobalData Clinical Trial Reports are generated using GlobalData's proprietary database - Pharma - Clinical trials database. Clinical trials are collated from 80+ different clinical trial registries, conferences, journals, news etc across the globe. Clinical trials database undergoes periodic update by dynamic process.

The report enhances the decision making capabilities and helps to create an effective counter strategies to gain competitive advantage.

Note: Certain sections in the report may be removed or altered based on the availability and relevance of data for the indicated disease.*

Scope

  • The report provides a snapshot of the global clinical trials landscape
  • Report provides top level data related to the clinical trials by Region, Country (G7 & E7), Trial Status, Trial Phase, Sponsor Type and End point status
  • The report reviews top companies involved and enlists all trials (Trial title, Phase, and Status) pertaining to the company
  • The report provides all the unaccomplished trials (Terminated, Suspended and Withdrawn) with reason for unaccomplishment
  • The Report provides enrollment trends for the past five years
  • Report provides latest news for the past three months

Note: Certain sections in the report may be removed or altered based on the availability and relevance of data for the indicated disease.

Reasons to Buy

  • Assists in formulating key business strategies with regards to investment
  • Helps in identifying prominent locations for conducting clinical trials which saves time and cost
  • Provides top level analysis of Global Clinical Trials Market which helps in identifying key business opportunities
  • Supports understanding of trials count and enrollment trends by country in global therapeutics market
  • Aids in interpreting the success rates of clinical trials by providing a comparative scenario of completed and uncompleted (terminated, suspended or withdrawn) trials
  • Facilitates clinical trial assessment of the indication on a global, regional and country level

Note: Certain sections in the report may be removed or altered based on the availability and relevance of data for the indicated disease.

Table of Contents

Table of Contents

List of Tables

List of Figures

  • Report Guidance
  • GlobalData Clinical Trials Report Coverage
  • Clinical Trials by Region
  • Clinical Trials and Average Enrollment by Country
  • Top Five Countries Contributing to Clinical Trials in Asia-Pacific
  • Top Five Countries Contributing to Clinical Trials in Europe
  • Top Countries Contributing to Clinical Trials in North America
  • Top Five Countries Contributing to Clinical Trials in Middle East and Africa
  • Top Five Countries Contributing to Clinical Trials in Central and South America
  • Clinical Trials by G7 Countries: Proportion of Burns to Dermatology Clinical Trials
  • Clinical Trials by Phase in G7 Countries
  • Clinical Trials in G7 Countries by Trial Status
  • Clinical Trials by E7 Countries: Proportion of Burns to Dermatology Clinical Trials
  • Clinical Trials by Phase in E7 Countries
  • Clinical Trials in E7 Countries by Trial Status
  • Clinical Trials by Phase
  • In Progress Trials by Phase
  • Clinical Trials by Trial Status
  • Clinical Trials by End Point Status
  • Subjects Recruited Over a Period of Time
  • Clinical Trials by Sponsor Type
  • Prominent Sponsors
  • Top Companies Participating in Burns Therapeutics Clinical Trials
  • Prominent Drugs
  • Clinical Trial Profile Snapshots

Appendix

  • Abbreviations
  • Definitions
  • Research Methodology
  • Secondary Research
  • About GlobalData
  • Contact Us
  • Source

List of Tables

List of Tables

  • Burns Therapeutics, Global, Clinical Trials by Region, 2020*
  • Burns Therapeutics, Global, Clinical Trials and Average Enrollment by Top Countries, 2020*
  • Burns Therapeutics, Global, Clinical Trials In Progress by Top Countries, 2020*
  • Burns Therapeutics Clinical Trials, Asia-Pacific, Top Five Countries, 2020*
  • Burns Therapeutics Clinical Trials, Europe, Top Five Countries, 2020*
  • Burns Therapeutics Clinical Trials, North America, Top Countries, 2020*
  • Burns Therapeutics Clinical Trials, Middle East and Africa, Top Five Countries, 2020*
  • Burns Therapeutics Clinical Trials, Central and South America, Top Five Countries, 2020*
  • Proportion of Burns to Dermatology Clinical Trials, G7 Countries (%), 2020*
  • Burns Therapeutics, G7 Countries, Clinical Trials by Phase, 2020*
  • Burns Therapeutics, G7 Countries, Clinical Trials by Trial Status, 2020*
  • Proportion of Burns to Dermatology Clinical Trials, E7 Countries (%), 2020*
  • Burns Therapeutics, E7 Countries, Clinical Trials by Phase, 2020*
  • Burns Therapeutics, E7 Countries, Clinical Trials by Trial Status, 2020*
  • Burns Therapeutics, Global, Clinical Trials by Phase, 2020*
  • Burns Therapeutics, Global, Clinical Trials In Progress by Phase 2020*
  • Burns Therapeutics, Global, Clinical Trials by Trial Status, 2020*
  • Burns Therapeutics Clinical Trials, Global, by End Point Status, 2020*
  • Burns Therapeutics Clinical Trials, Global, Average Enrollment Target Trends, 2015-2019
  • Burns Therapeutics Market, Global, Clinical Trials by Sponsor Type, 2020*
  • Burns Therapeutics Clinical Trials, Global, Key Sponsors, 2020*
  • Burns Therapeutics Clinical Trials, Global, Top Companies by Phase, 2020*
  • Burns Therapeutics Clinical Trials, Global, Ongoing Clinical Trials by Prominent Drugs, 2020*

List of Figures

List of Figures

  • Burns Therapeutics, Global, Clinical Trials by Region (%), 2020*
  • Burns Therapeutics, Global, Clinical Trials and Average Enrollment by Top Countries, 2020*
  • Burns Therapeutics, Global, Clinical Trials In Progress by Top Countries, 2020*
  • Burns Therapeutics Clinical Trials, Asia-Pacific, Top Five Countries (%), 2020*
  • Burns Therapeutics Clinical Trials, Europe, Top Five Countries (%), 2020*
  • Burns Therapeutics Clinical Trials, North America, Top Countries (%), 2020*
  • Burns Therapeutics Clinical Trials, Middle East and Africa, Top Five Countries (%), 2020*
  • Burns Therapeutics Clinical Trials, Central and South America, Top Five Countries (%), 2020*
  • Proportion of Burns to Dermatology Clinical Trials, G7 Countries (%), 2020*
  • Burns Therapeutics, G7 Countries, Clinical Trials by Phase, 2020*
  • Burns Therapeutics, G7 Countries, Clinical Trials by Trial Status, 2020*
  • Proportion of Burns to Dermatology Clinical Trials, E7 Countries (%), 2020*
  • Burns Therapeutics, E7 Countries, Clinical Trials by Phase, 2020*
  • Burns Therapeutics, E7 Countries, Clinical Trials by Trial Status, 2020*
  • Burns Therapeutics, Global, Clinical Trials by Phase (%), 2020*
  • Burns Therapeutics, Global, Clinical Trials In Progress by Phase, 2020*
  • Burns Therapeutics, Global, Clinical Trials by Trial Status, 2020*
  • Burns Therapeutics Clinical Trials, Global, by End Point Status, 2020*
  • Burns Therapeutics Clinical Trials, Global, Average Enrollment Target Trends, 2015-2019
  • Burns Therapeutics Market, Global, Clinical Trials by Sponsor Type (%), 2020*
  • Burns Therapeutics Clinical Trials, Global, Key Sponsors, 2020*
  • Burns Therapeutics Clinical Trials, Global, Top Companies by Phase, 2020*
  • Burns Therapeutics Clinical Trials, Global, Ongoing Clinical Trials by Prominent Drugs, 2020*
  • GlobalData Methodology